Wed, Nov 26, 2014, 2:48 AM EST - U.S. Markets open in 6 hrs 42 mins

Recent

% | $
Quotes you view appear here for quick access.

Santarus, Inc. (SNTS) Message Board

  • hofno2003 hofno2003 Feb 17, 2013 3:04 AM Flag

    OT: siamesekitty - maybe you are interested in NLNK and its ....

    hyperacute technology platform. 3 late stage projects ongoing, pancreas is the most advanced. I am a beliver of the HyperAcute Technology approach of NLNK. A lot of cash, no relevant debt, relatively low market cap in regard of the market potential for pancreas (phase III), melanoma (phase II) and lung (NSCL, phase II/III). Phase II data for pancreas have demonstrated dose dependant efficacy and a significant treatment effect. Phase III interim analysis is defined and could stop phase III for efficacy early (in H1/2013, 45% improvement in OS is the threshold for early termination for efficacy at 222 evaluable patients/events for IA). SPA, fast track, all given.

    Hofno

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SNTS
31.960.00(0.00%)Dec 31 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.